These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11044479)

  • 21. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
    Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
    Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
    Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
    Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.
    Aziz NM; Guedj F; Pennings JLA; Olmos-Serrano JL; Siegel A; Haydar TF; Bianchi DW
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A behavioral assessment of Ts65Dn mice: a putative Down syndrome model.
    Escorihuela RM; Fernández-Teruel A; Vallina IF; Baamonde C; Lumbreras MA; Dierssen M; Tobeña A; Flórez J
    Neurosci Lett; 1995 Oct; 199(2):143-6. PubMed ID: 8584244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.
    Richtsmeier JT; Baxter LL; Reeves RH
    Dev Dyn; 2000 Feb; 217(2):137-45. PubMed ID: 10706138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome.
    Adams AD; Hoffmann V; Koehly L; Guedj F; Bianchi DW
    Am J Obstet Gynecol; 2021 Sep; 225(3):296.e1-296.e13. PubMed ID: 33766516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome.
    Shichiri M; Yoshida Y; Ishida N; Hagihara Y; Iwahashi H; Tamai H; Niki E
    Free Radic Biol Med; 2011 Jun; 50(12):1801-11. PubMed ID: 21447382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hippocampal hypocellularity in the Ts65Dn mouse originates early in development.
    Lorenzi HA; Reeves RH
    Brain Res; 2006 Aug; 1104(1):153-9. PubMed ID: 16828061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymerase chain reaction method to identify Down syndrome model segmentally trisomic mice.
    Ramakrishna N; Meeker C; Li S; Jenkins EC; Currie JR; Flory M; Lee B; Liu MS; Miller DL
    Anal Biochem; 2005 May; 340(2):213-9. PubMed ID: 15840493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801.
    Siddiqui A; Lacroix T; Stasko MR; Scott-McKean JJ; Costa AC; Gardiner KJ
    Genes Brain Behav; 2008 Oct; 7(7):810-20. PubMed ID: 19125866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.
    Vacík T; Ort M; Gregorová S; Strnad P; Blatny R; Conte N; Bradley A; Bures J; Forejt J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4500-5. PubMed ID: 15755806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome.
    Hampton TG; Stasko MR; Kale A; Amende I; Costa AC
    Physiol Behav; 2004 Sep; 82(2-3):381-9. PubMed ID: 15276802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome.
    Duchon A; Raveau M; Chevalier C; Nalesso V; Sharp AJ; Herault Y
    Mamm Genome; 2011 Dec; 22(11-12):674-84. PubMed ID: 21953411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1).
    Costa AC; Stasko MR; Schmidt C; Davisson MT
    Behav Brain Res; 2010 Jan; 206(1):52-62. PubMed ID: 19720087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development.
    Potier MC; Rivals I; Mercier G; Ettwiller L; Moldrich RX; Laffaire J; Personnaz L; Rossier J; Dauphinot L
    J Neurochem; 2006 Apr; 97 Suppl 1():104-9. PubMed ID: 16635258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the cardiac phenotype in neonatal Ts65Dn mice.
    Williams AD; Mjaatvedt CH; Moore CS
    Dev Dyn; 2008 Feb; 237(2):426-35. PubMed ID: 18161058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ts65Dn -- localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome.
    Akeson EC; Lambert JP; Narayanswami S; Gardiner K; Bechtel LJ; Davisson MT
    Cytogenet Cell Genet; 2001; 93(3-4):270-6. PubMed ID: 11528125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome.
    Rueda N; Llorens-Martín M; Flórez J; Valdizán E; Banerjee P; Trejo JL; Martínez-Cué C
    J Alzheimers Dis; 2010; 21(1):277-90. PubMed ID: 20421694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficits of neuronal density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a mouse model of Down syndrome.
    Kurt MA; Kafa MI; Dierssen M; Davies DC
    Brain Res; 2004 Oct; 1022(1-2):101-9. PubMed ID: 15353219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.
    Di Filippo M; Tozzi A; Ghiglieri V; Picconi B; Costa C; Cipriani S; Tantucci M; Belcastro V; Calabresi P
    Biol Psychiatry; 2010 Apr; 67(7):666-71. PubMed ID: 19818432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.